The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment

BACKGROUND: Systemic therapy prolongs overall survival (OS) in advanced non‐small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular profiling take time, and this can delay therapy initiation. OS approximates first‐order kinetics. METHODS: We used OS of chemo‐naive NSCLC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, David J., Maziak, Donna E., Moore, Sara M., Brule, Stephanie Y., Gomes, Marcio, Sekhon, Harman, Dennie, Carole, Lo, Bryan, Fung‐Kee‐Fung, Michael, Bradford, John‐Peter, Reaume, Martin Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683556/
https://www.ncbi.nlm.nih.gov/pubmed/34766461
http://dx.doi.org/10.1002/cam4.4411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683556/
https://www.ncbi.nlm.nih.gov/pubmed/34766461
http://dx.doi.org/10.1002/cam4.4411

Ejemplares similares